{"count": 33, "results": [{"_id": "34434111", "pmid": 34434111, "pmcid": "PMC8381252", "title": "Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway", "journal": "Front Pharmacol", "authors": ["Li SX", "Li C", "Pang XR", "Zhang J", "Yu GC", "Yeo AJ", "Lavin MF", "Shao H", "Jia Q", "Peng C"], "date": "2021-08-09T00:00:00Z", "doi": "10.3389/fphar.2021.719589", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "719589", "score": 50261.62, "text_hl": "Our results showed that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ significantly alleviated the @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ and @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@fibrosis@@@ of @<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@lung@@@ tissues of @SPECIES_10116 @@@rats@@@ exposed to @CHEMICAL_Silicon_Dioxide @CHEMICAL_MESH:D012822 @@@silica@@@ particles. ", "citations": {"NLM": "Li SX, Li C, Pang XR, Zhang J, Yu GC, Yeo AJ, Lavin MF, Shao H, Jia Q, Peng C. Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway Front Pharmacol. 2021;12():719589. PMID: 34434111", "BibTeX": "@article{34434111, title={Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway}, author={Li SX and Li C and Pang XR and Zhang J and Yu GC and Yeo AJ and Lavin MF and Shao H and Jia Q and Peng C}, journal={Front Pharmacol}, volume={12}, pages={719589}}"}}, {"_id": "33200330", "pmid": 33200330, "pmcid": "PMC7669792", "title": "Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers", "journal": "AAPS J", "authors": ["Acosta MF", "Abrahamson MD", "Encinas-Basurto D", "Fineman JR", "Black SM", "Mansour HM"], "date": "2020-11-16T00:00:00Z", "doi": "10.1208/s12248-020-00531-3", "meta_date_publication": "2020 Nov 16", "meta_volume": "23", "meta_issue": "1", "meta_pages": "2", "score": 50256.285, "text_hl": "Thus, these important pharmacological properties make @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ a candidate to treat complex @<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@pulmonary diseases@@@ that continue to have unmet medical needs.", "citations": {"NLM": "Acosta MF, Abrahamson MD, Encinas-Basurto D, Fineman JR, Black SM, Mansour HM. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers AAPS J. 2020 Nov 16;23(1):2. PMID: 33200330", "BibTeX": "@article{33200330, title={Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers}, author={Acosta MF and Abrahamson MD and Encinas-Basurto D and Fineman JR and Black SM and Mansour HM}, journal={AAPS J}, volume={23}, number={1}, pages={2}}"}}, {"_id": "34033525", "pmid": 34033525, "title": "Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment.", "journal": "Am J Respir Crit Care Med", "authors": ["Polverino F", "Wu TD", "Rojas-Quintero J", "Wang X", "Mayo J", "Tomchaney M", "Tram J", "Packard S", "Zhang D", "Cleveland KH", "Cordoba-Lanus E", "Owen CA", "Fawzy A", "Kinney GL", "Hersh CP", "Hansel NN", "Doubleday K", "Sauler M", "Tesfaigzi Y", "Ledford JG", "Casanova C", "Zmijewski J", "Konhilas J", "Langlais PR", "Schnellmann R", "Rahman I", "McCormack M", "Celli B"], "date": "2021-09-15T00:00:00Z", "doi": "10.1164/rccm.202012-4510OC", "meta_date_publication": "2021 Sep 15", "meta_volume": "204", "meta_issue": "6", "meta_pages": "651-666", "score": 50256.258, "text_hl": "@<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@Lung@@@, @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@kidney, and muscle pathologies@@@, @<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@lung@@@ proteostasis, endoplasmic reticulum (ER) stress, mitochondrial function, and mediators of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ effects in vivo and/or in vitro were studied. ", "citations": {"NLM": "Polverino F, Wu TD, Rojas-Quintero J, Wang X, Mayo J, Tomchaney M, Tram J, Packard S, Zhang D, Cleveland KH, Cordoba-Lanus E, Owen CA, Fawzy A, Kinney GL, Hersh CP, Hansel NN, Doubleday K, Sauler M, Tesfaigzi Y, Ledford JG, Casanova C, Zmijewski J, Konhilas J, Langlais PR, Schnellmann R, Rahman I, McCormack M, Celli B. Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment. Am J Respir Crit Care Med. 2021 Sep 15;204(6):651-666. PMID: 34033525", "BibTeX": "@article{34033525, title={Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment.}, author={Polverino F and Wu TD and Rojas-Quintero J and Wang X and Mayo J and Tomchaney M and Tram J and Packard S and Zhang D and Cleveland KH and Cordoba-Lanus E and Owen CA and Fawzy A and Kinney GL and Hersh CP and Hansel NN and Doubleday K and Sauler M and Tesfaigzi Y and Ledford JG and Casanova C and Zmijewski J and Konhilas J and Langlais PR and Schnellmann R and Rahman I and McCormack M and Celli B}, journal={Am J Respir Crit Care Med}, volume={204}, number={6}, pages={651-666}}"}}, {"_id": "34209135", "pmid": 34209135, "pmcid": "PMC8268757", "title": "Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells", "journal": "Int J Mol Sci", "authors": ["Hansel C", "Barr S", "Schemann AV", "Lauber K", "Hess J", "Unger K", "Zitzelsberger H", "Jendrossek V", "Klein D"], "date": "2021-06-30T00:00:00Z", "doi": "10.3390/ijms22137064", "meta_date_publication": "2021 Jun 30", "meta_volume": "22", "meta_issue": "13", "meta_pages": "", "score": 50255.99, "text_hl": "It has been supposed that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can limit the onset and duration of a cytokine storm-like responses, particularly upon @<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@lung damage@@@ thereby preventing excessive @<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@lung damage@@@. ", "citations": {"NLM": "Hansel C, Barr S, Schemann AV, Lauber K, Hess J, Unger K, Zitzelsberger H, Jendrossek V, Klein D. Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells Int J Mol Sci. 2021 Jun 30;22(13):. PMID: 34209135", "BibTeX": "@article{34209135, title={Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells}, author={Hansel C and Barr S and Schemann AV and Lauber K and Hess J and Unger K and Zitzelsberger H and Jendrossek V and Klein D}, journal={Int J Mol Sci}, volume={22}, number={13}}"}}, {"_id": "35440331", "pmid": 35440331, "title": "Evaluation of the Mitigation Effect of Spirulina Against Lung Injury Induced by Radiation in Rats.", "journal": "Curr Radiopharm", "authors": ["Ahmadvand MH", "Nikzad S", "Changizi V", "Pashaki AS", "Najafi M", "Mirzaei F"], "date": "2022-04-18T00:00:00Z", "doi": "10.2174/1874471015666220418133919", "meta_date_publication": "2022 Apr 18", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50250.777, "text_hl": "Both @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @SPECIES_551299 @@@Spirulina@@@ increased the SOD and GPx activity in @<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@lung@@@ tissue. ", "citations": {"NLM": "Ahmadvand MH, Nikzad S, Changizi V, Pashaki AS, Najafi M, Mirzaei F. Evaluation of the Mitigation Effect of Spirulina Against Lung Injury Induced by Radiation in Rats. Curr Radiopharm. 2022 Apr 18;():. PMID: 35440331", "BibTeX": "@article{35440331, title={Evaluation of the Mitigation Effect of Spirulina Against Lung Injury Induced by Radiation in Rats.}, author={Ahmadvand MH and Nikzad S and Changizi V and Pashaki AS and Najafi M and Mirzaei F}, journal={Curr Radiopharm}}"}}, {"_id": "36688306", "pmid": 36688306, "title": "Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation.", "journal": "Nutr Cancer", "authors": ["Elton AC", "Cedarstrom V", "Quraishi A", "Wuertz B", "Murray K", "Markowski TW", "Seabloom D", "Ondrey FG"], "date": "2023-01-01T00:00:00Z", "doi": "10.1080/01635581.2023.2165692", "meta_date_publication": "2023", "meta_volume": "75", "meta_issue": "3", "meta_pages": "1014-1027", "score": 50250.31, "text_hl": "Metabolomic analysis revealed metabolite alterations consistent with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment. Based on these results, we conclude that previous reductions in @<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@lung adenomas@@@ may have been occurred from anticancer effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ rather than a potentially toxic effect such as calorie restriction.", "citations": {"NLM": "Elton AC, Cedarstrom V, Quraishi A, Wuertz B, Murray K, Markowski TW, Seabloom D, Ondrey FG. Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation. Nutr Cancer. 2023;75(3):1014-1027. PMID: 36688306", "BibTeX": "@article{36688306, title={Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation.}, author={Elton AC and Cedarstrom V and Quraishi A and Wuertz B and Murray K and Markowski TW and Seabloom D and Ondrey FG}, journal={Nutr Cancer}, volume={75}, number={3}, pages={1014-1027}}"}}, {"_id": "36007338", "pmid": 36007338, "title": "Immunologic and imaging signatures in post tuberculosis lung disease.", "journal": "Tuberculosis (Edinb)", "authors": ["Singh S", "Allwood BW", "Chiyaka TL", "Kleyhans L", "Naidoo CC", "Moodley S", "Theron G", "Segal LN"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.tube.2022.102244", "meta_date_publication": "2022 Sep", "meta_volume": "136", "meta_issue": "", "meta_pages": "102244", "score": 50249.73, "text_hl": "Next, we discuss the role of novel host directed therapies (HDT) to limit the development of @<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@PTLD@@@ and in particular, the recent repurposing of established medications such as statins, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Doxycycline @CHEMICAL_MESH:D004318 @@@doxycycline@@@. ", "citations": {"NLM": "Singh S, Allwood BW, Chiyaka TL, Kleyhans L, Naidoo CC, Moodley S, Theron G, Segal LN. Immunologic and imaging signatures in post tuberculosis lung disease. Tuberculosis (Edinb). 2022 Sep;136():102244. PMID: 36007338", "BibTeX": "@article{36007338, title={Immunologic and imaging signatures in post tuberculosis lung disease.}, author={Singh S and Allwood BW and Chiyaka TL and Kleyhans L and Naidoo CC and Moodley S and Theron G and Segal LN}, journal={Tuberculosis (Edinb)}, volume={136}, pages={102244}}"}}, {"_id": "37501618", "pmid": 37501618, "title": "Metformin ameliorates cardiopulmonary toxicity induced by chlorpyrifos.", "journal": "Drug Chem Toxicol", "authors": ["Farhadi R", "Daniali M", "Baeeri M", "Foroumadi R", "Gholami M", "Hassani S", "Mirzababaei S", "Haghi-Aminjan H", "Navaei-Nigjeh M", "Rahimifard M", "Abdollahi M"], "date": "2023-07-28T00:00:00Z", "doi": "10.1080/01480545.2023.2239523", "meta_date_publication": "2023 Jul 28", "meta_volume": "", "meta_issue": "", "meta_pages": "1-13", "score": 50248.895, "text_hl": "This study aimed to investigate the modulatory impacts of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @CHEMICAL_Chlorpyrifos @CHEMICAL_MESH:D004390 @@@CPF@@@-induced @<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@heart and lung damage@@@. ", "citations": {"NLM": "Farhadi R, Daniali M, Baeeri M, Foroumadi R, Gholami M, Hassani S, Mirzababaei S, Haghi-Aminjan H, Navaei-Nigjeh M, Rahimifard M, Abdollahi M. Metformin ameliorates cardiopulmonary toxicity induced by chlorpyrifos. Drug Chem Toxicol. 2023 Jul 28;():1-13. PMID: 37501618", "BibTeX": "@article{37501618, title={Metformin ameliorates cardiopulmonary toxicity induced by chlorpyrifos.}, author={Farhadi R and Daniali M and Baeeri M and Foroumadi R and Gholami M and Hassani S and Mirzababaei S and Haghi-Aminjan H and Navaei-Nigjeh M and Rahimifard M and Abdollahi M}, journal={Drug Chem Toxicol}, pages={1-13}}"}}, {"_id": "35093884", "pmid": 35093884, "title": "Enhancement of Radiation Response Associated With Metformin in Hepatocellular Carcinoma: Preclinical Animal and Clinical Cohort Study.", "journal": "Anticancer Res", "authors": ["Jang WI", "Kim MS", "Jeong JH", "Kim W", "Kim JS"], "date": "2022-02-01T00:00:00Z", "doi": "10.21873/anticanres.15544", "meta_date_publication": "2022 Feb", "meta_volume": "42", "meta_issue": "2", "meta_pages": "867-876", "score": 50248.656, "text_hl": "RESULTS: The combinations of gamma-ray and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and neutron radiation and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ inhibited @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumour@@@ growth and metastatic @<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@lung@@@ nodule formation when compared to the monotherapy and gamma-ray groups, respectively. ", "citations": {"NLM": "Jang WI, Kim MS, Jeong JH, Kim W, Kim JS. Enhancement of Radiation Response Associated With Metformin in Hepatocellular Carcinoma: Preclinical Animal and Clinical Cohort Study. Anticancer Res. 2022 Feb;42(2):867-876. PMID: 35093884", "BibTeX": "@article{35093884, title={Enhancement of Radiation Response Associated With Metformin in Hepatocellular Carcinoma: Preclinical Animal and Clinical Cohort Study.}, author={Jang WI and Kim MS and Jeong JH and Kim W and Kim JS}, journal={Anticancer Res}, volume={42}, number={2}, pages={867-876}}"}}, {"_id": "33004826", "pmid": 33004826, "pmcid": "PMC7530990", "title": "Metformin enhances protection in guinea pigs chronically infected with Mycobacterium tuberculosis", "journal": "Sci Rep", "authors": ["Frenkel JDH", "Ackart DF", "Todd AK", "DiLisio JE", "Hoffman S", "Tanner S", "Kiran D", "Murray M", "Chicco A", "Obregón-Henao A", "Podell BK", "Basaraba RJ"], "date": "2020-10-01T00:00:00Z", "doi": "10.1038/s41598-020-73212-y", "meta_date_publication": "2020 Oct 1", "meta_volume": "10", "meta_issue": "1", "meta_pages": "16257", "score": 50246.547, "text_hl": "Despite persistent @DISEASE_Glucose_Intolerance @DISEASE_MESH:D018149 @@@glucose intolerance@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated @SPECIES_10141 @@@guinea pigs@@@ had a 2.8-fold reduction in @<m>DISEASE_Lung_Diseases</m> @DISEASE_MESH:D008171 @@@lung lesion@@@ burden and a 0.7 log decrease in CFUs. ", "citations": {"NLM": "Frenkel JDH, Ackart DF, Todd AK, DiLisio JE, Hoffman S, Tanner S, Kiran D, Murray M, Chicco A, Obregón-Henao A, Podell BK, Basaraba RJ. Metformin enhances protection in guinea pigs chronically infected with Mycobacterium tuberculosis Sci Rep. 2020 Oct 1;10(1):16257. PMID: 33004826", "BibTeX": "@article{33004826, title={Metformin enhances protection in guinea pigs chronically infected with Mycobacterium tuberculosis}, author={Frenkel JDH and Ackart DF and Todd AK and DiLisio JE and Hoffman S and Tanner S and Kiran D and Murray M and Chicco A and Obregón-Henao A and Podell BK and Basaraba RJ}, journal={Sci Rep}, volume={10}, number={1}, pages={16257}}"}}]}